APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alternative to Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alternative to Antibiotics Market Analysis and Forecast 2026-2032

Report ID 17396242022 January 2026218 pages

Choose your research edition.

Industry ResearchAlternative to Antibiotics Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Alternative to Antibiotics Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Alternative to Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alternative to Antibiotics Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Alternative to Antibiotics Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Alternative to Antibiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alternative to Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alternative to Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alternative to Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alternative to Antibiotics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Alternative to Antibiotics include DSM, BioGaia, Bioriginal, Biosearch Life, China-Biotics, Chr. Hansen, Danone, DuPont(Danisco) and Ganeden, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alternative to Antibiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alternative to Antibiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Alternative to Antibiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alternative to Antibiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alternative to Antibiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alternative to Antibiotics sales, projected growth trends, production technology, application and end-user industry.

Alternative to Antibiotics Segment by Company

DSM

BioGaia

Bioriginal

Biosearch Life

China-Biotics

Chr. Hansen

Danone

DuPont(Danisco)

Ganeden

Glory Biotech

Greentech

Lallemand

Morinaga Milk Industry

Novozymes

Probi

Sabinsa

Synbiotech

UAS Laboratories

Valio

Yakult

Nestle

Alternative to Antibiotics Segment by Type

Antimicrobial Proteins

Bacteriophages

Probiotics

Other

Alternative to Antibiotics Segment by Application

Drugs

Food & Beverage

Dietary Supplements

Alternative to Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative to Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alternative to Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative to Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alternative to Antibiotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alternative to Antibiotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alternative to Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antimicrobial Proteins Major Manufacturers Table 3. Bacteriophages Major Manufacturers Table 4. Probiotics Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Alternative to Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Drugs Major Manufacturers Table 8. Food & Beverage Major Manufacturers Table 9. Dietary Supplements Major Manufacturers Table 10. Alternative to Antibiotics Industry Trends Table 11. Alternative to Antibiotics Industry Drivers Table 12. Alternative to Antibiotics Industry Opportunities and Challenges Table 13. Alternative to Antibiotics Industry Restraints Table 14. Global Alternative to Antibiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Alternative to Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Alternative to Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Alternative to Antibiotics Revenue Market Share by Region (2021-2026) Table 18. Global Alternative to Antibiotics Revenue Market Share by Region (2027-2032) Table 19. Global Alternative to Antibiotics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Alternative to Antibiotics Sales by Region (2021-2026) & (K Units) Table 21. Global Alternative to Antibiotics Sales by Region (2027-2032) & (K Units) Table 22. Global Alternative to Antibiotics Sales Market Share by Region (2021-2026) Table 23. Global Alternative to Antibiotics Sales Market Share by Region (2027-2032) Table 24. Global Alternative to Antibiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Alternative to Antibiotics Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Alternative to Antibiotics Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Alternative to Antibiotics Sales Market Share by Manufacturers (2021-2026) Table 28. Global Alternative to Antibiotics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Alternative to Antibiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Alternative to Antibiotics Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Alternative to Antibiotics Manufacturers, Product Type & Application Table 32. Global Alternative to Antibiotics Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Alternative to Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Alternative to Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Alternative to Antibiotics Revenue Market Share by Type (2021-2026) Table 39. Global Alternative to Antibiotics Revenue Market Share by Type (2027-2032) Table 40. Global Alternative to Antibiotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 42. Global Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 43. Global Alternative to Antibiotics Sales Market Share by Type (2021-2026) Table 44. Global Alternative to Antibiotics Sales Market Share by Type (2027-2032) Table 45. Global Alternative to Antibiotics Price by Type (2021-2026) & (US$/Unit) Table 46. Global Alternative to Antibiotics Price by Type (2027-2032) & (US$/Unit) Table 47. Global Alternative to Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Alternative to Antibiotics Revenue Market Share by Application (2021-2026) Table 51. Global Alternative to Antibiotics Revenue Market Share by Application (2027-2032) Table 52. Global Alternative to Antibiotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 54. Global Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 55. Global Alternative to Antibiotics Sales Market Share by Application (2021-2026) Table 56. Global Alternative to Antibiotics Sales Market Share by Application (2027-2032) Table 57. Global Alternative to Antibiotics Price by Application (2021-2026) & (US$/Unit) Table 58. Global Alternative to Antibiotics Price by Application (2027-2032) & (US$/Unit) Table 59. DSM Company Information Table 60. DSM Business Overview Table 61. DSM Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. DSM Alternative to Antibiotics Product Portfolio Table 63. DSM Recent Development Table 64. BioGaia Company Information Table 65. BioGaia Business Overview Table 66. BioGaia Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. BioGaia Alternative to Antibiotics Product Portfolio Table 68. BioGaia Recent Development Table 69. Bioriginal Company Information Table 70. Bioriginal Business Overview Table 71. Bioriginal Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bioriginal Alternative to Antibiotics Product Portfolio Table 73. Bioriginal Recent Development Table 74. Biosearch Life Company Information Table 75. Biosearch Life Business Overview Table 76. Biosearch Life Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biosearch Life Alternative to Antibiotics Product Portfolio Table 78. Biosearch Life Recent Development Table 79. China-Biotics Company Information Table 80. China-Biotics Business Overview Table 81. China-Biotics Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. China-Biotics Alternative to Antibiotics Product Portfolio Table 83. China-Biotics Recent Development Table 84. Chr. Hansen Company Information Table 85. Chr. Hansen Business Overview Table 86. Chr. Hansen Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Chr. Hansen Alternative to Antibiotics Product Portfolio Table 88. Chr. Hansen Recent Development Table 89. Danone Company Information Table 90. Danone Business Overview Table 91. Danone Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Danone Alternative to Antibiotics Product Portfolio Table 93. Danone Recent Development Table 94. DuPont(Danisco) Company Information Table 95. DuPont(Danisco) Business Overview Table 96. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. DuPont(Danisco) Alternative to Antibiotics Product Portfolio Table 98. DuPont(Danisco) Recent Development Table 99. Ganeden Company Information Table 100. Ganeden Business Overview Table 101. Ganeden Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Ganeden Alternative to Antibiotics Product Portfolio Table 103. Ganeden Recent Development Table 104. Glory Biotech Company Information Table 105. Glory Biotech Business Overview Table 106. Glory Biotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Glory Biotech Alternative to Antibiotics Product Portfolio Table 108. Glory Biotech Recent Development Table 109. Greentech Company Information Table 110. Greentech Business Overview Table 111. Greentech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Greentech Alternative to Antibiotics Product Portfolio Table 113. Greentech Recent Development Table 114. Lallemand Company Information Table 115. Lallemand Business Overview Table 116. Lallemand Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Lallemand Alternative to Antibiotics Product Portfolio Table 118. Lallemand Recent Development Table 119. Morinaga Milk Industry Company Information Table 120. Morinaga Milk Industry Business Overview Table 121. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Morinaga Milk Industry Alternative to Antibiotics Product Portfolio Table 123. Morinaga Milk Industry Recent Development Table 124. Novozymes Company Information Table 125. Novozymes Business Overview Table 126. Novozymes Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Novozymes Alternative to Antibiotics Product Portfolio Table 128. Novozymes Recent Development Table 129. Probi Company Information Table 130. Probi Business Overview Table 131. Probi Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Probi Alternative to Antibiotics Product Portfolio Table 133. Probi Recent Development Table 134. Sabinsa Company Information Table 135. Sabinsa Business Overview Table 136. Sabinsa Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Sabinsa Alternative to Antibiotics Product Portfolio Table 138. Sabinsa Recent Development Table 139. Synbiotech Company Information Table 140. Synbiotech Business Overview Table 141. Synbiotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Synbiotech Alternative to Antibiotics Product Portfolio Table 143. Synbiotech Recent Development Table 144. UAS Laboratories Company Information Table 145. UAS Laboratories Business Overview Table 146. UAS Laboratories Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. UAS Laboratories Alternative to Antibiotics Product Portfolio Table 148. UAS Laboratories Recent Development Table 149. Valio Company Information Table 150. Valio Business Overview Table 151. Valio Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Valio Alternative to Antibiotics Product Portfolio Table 153. Valio Recent Development Table 154. Yakult Company Information Table 155. Yakult Business Overview Table 156. Yakult Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Yakult Alternative to Antibiotics Product Portfolio Table 158. Yakult Recent Development Table 159. Nestle Company Information Table 160. Nestle Business Overview Table 161. Nestle Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Nestle Alternative to Antibiotics Product Portfolio Table 163. Nestle Recent Development Table 164. North America Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 165. North America Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 166. North America Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 167. North America Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 168. North America Alternative to Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 169. North America Alternative to Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 170. North America Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 171. North America Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 172. North America Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 173. North America Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 174. North America Alternative to Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 175. North America Alternative to Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 176. North America Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. North America Alternative to Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. North America Alternative to Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. North America Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. North America Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 181. North America Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 182. North America Alternative to Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 183. North America Alternative to Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 184. United States Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 185. Canada Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 186. Europe Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 187. Europe Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 188. Europe Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 189. Europe Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 190. Europe Alternative to Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 191. Europe Alternative to Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 192. Europe Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 193. Europe Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 194. Europe Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 195. Europe Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 196. Europe Alternative to Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 197. Europe Alternative to Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 198. Europe Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Europe Alternative to Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Europe Alternative to Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Europe Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 202. Europe Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 203. Europe Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 204. Europe Alternative to Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 205. Europe Alternative to Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 206. Germany Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 207. France Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 208. U.K. Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 209. Italy Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 210. Netherlands Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 211. China Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 212. China Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 213. China Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 214. China Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 215. China Alternative to Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 216. China Alternative to Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 217. China Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 218. China Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 219. China Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 220. China Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 221. China Alternative to Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 222. China Alternative to Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 223. Asia Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 226. Asia Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 227. Asia Alternative to Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 228. Asia Alternative to Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 229. Asia Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 230. Asia Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 231. Asia Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 232. Asia Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 233. Asia Alternative to Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 234. Asia Alternative to Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 235. Asia Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Alternative to Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Alternative to Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 239. Asia Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 240. Asia Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 241. Asia Alternative to Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 242. Asia Alternative to Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 243. Japan Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 244. South Korea Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 245. India Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 246. Australia Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 247. China Taiwan Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 252. SAMEA Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 253. SAMEA Alternative to Antibiotics Sales Price by Type (2021-2026) & (US$/Unit) Table 254. SAMEA Alternative to Antibiotics Sales Price by Type (2027-2032) & (US$/Unit) Table 255. SAMEA Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 256. SAMEA Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 257. SAMEA Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 258. SAMEA Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 259. SAMEA Alternative to Antibiotics Sales Price by Application (2021-2026) & (US$/Unit) Table 260. SAMEA Alternative to Antibiotics Sales Price by Application (2027-2032) & (US$/Unit) Table 261. SAMEA Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Alternative to Antibiotics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Alternative to Antibiotics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 265. SAMEA Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 266. SAMEA Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 267. SAMEA Alternative to Antibiotics Sales Price by Country (2021-2026) & (US$/Unit) Table 268. SAMEA Alternative to Antibiotics Sales Price by Country (2027-2032) & (US$/Unit) Table 269. Brazil Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 270. Argentina Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 271. Chile Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 272. Colombia Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 273. Peru Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 275. Israel Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 276. UAE Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 277. Turkey Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 278. Iran Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 279. Egypt Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Alternative to Antibiotics Distributors List Table 283. Alternative to Antibiotics Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Alternative to Antibiotics Image Figure 2. Global Alternative to Antibiotics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alternative to Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antimicrobial Proteins Image Figure 5. Bacteriophages Image Figure 6. Probiotics Image Figure 7. Other Image Figure 8. Global Alternative to Antibiotics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Alternative to Antibiotics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Drugs Image Figure 11. Food & Beverage Image Figure 12. Dietary Supplements Image Figure 13. Global Alternative to Antibiotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Alternative to Antibiotics Revenue (2021-2032) & (US$ Million) Figure 15. Global Alternative to Antibiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Alternative to Antibiotics Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Alternative to Antibiotics Revenue Market Share by Region (2021-2032) Figure 18. Global Alternative to Antibiotics Sales (2021-2032) & (K Units) Figure 19. Global Alternative to Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Alternative to Antibiotics Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Alternative to Antibiotics Sales YoY (2021-2032) & (K Units) Figure 22. Europe Alternative to Antibiotics Sales YoY (2021-2032) & (K Units) Figure 23. China Alternative to Antibiotics Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Alternative to Antibiotics Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Alternative to Antibiotics Sales YoY (2021-2032) & (K Units) Figure 26. Global Alternative to Antibiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Alternative to Antibiotics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Alternative to Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Alternative to Antibiotics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Alternative to Antibiotics Revenue Market Share by Type (2021-2032) Figure 32. Global Alternative to Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Alternative to Antibiotics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Alternative to Antibiotics Sales Market Share by Type (2021-2032) Figure 35. Global Alternative to Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Alternative to Antibiotics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Alternative to Antibiotics Revenue Market Share by Application (2021-2032) Figure 38. Global Alternative to Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Alternative to Antibiotics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Alternative to Antibiotics Sales Market Share by Application (2021-2032) Figure 41. North America Alternative to Antibiotics Revenue Share by Type (2021-2032) Figure 42. North America Alternative to Antibiotics Sales Share by Type (2021-2032) Figure 43. North America Alternative to Antibiotics Revenue Share by Application (2021-2032) Figure 44. North America Alternative to Antibiotics Sales Share by Application (2021-2032) Figure 45. North America Alternative to Antibiotics Revenue Share by Country (2021-2032) Figure 46. North America Alternative to Antibiotics Sales Share by Country (2021-2032) Figure 47. Europe Alternative to Antibiotics Revenue Share by Type (2021-2032) Figure 48. Europe Alternative to Antibiotics Sales Share by Type (2021-2032) Figure 49. Europe Alternative to Antibiotics Revenue Share by Application (2021-2032) Figure 50. Europe Alternative to Antibiotics Sales Share by Application (2021-2032) Figure 51. Europe Alternative to Antibiotics Revenue Share by Country (2021-2032) Figure 52. Europe Alternative to Antibiotics Sales Share by Country (2021-2032) Figure 53. China Alternative to Antibiotics Revenue Share by Type (2021-2032) Figure 54. China Alternative to Antibiotics Sales Share by Type (2021-2032) Figure 55. China Alternative to Antibiotics Revenue Share by Application (2021-2032) Figure 56. China Alternative to Antibiotics Sales Share by Application (2021-2032) Figure 57. Asia Alternative to Antibiotics Revenue Share by Type (2021-2032) Figure 58. Asia Alternative to Antibiotics Sales Share by Type (2021-2032) Figure 59. Asia Alternative to Antibiotics Revenue Share by Application (2021-2032) Figure 60. Asia Alternative to Antibiotics Sales Share by Application (2021-2032) Figure 61. Asia Alternative to Antibiotics Revenue Share by Country (2021-2032) Figure 62. Asia Alternative to Antibiotics Sales Share by Country (2021-2032) Figure 63. SAMEA Alternative to Antibiotics Revenue Share by Type (2021-2032) Figure 64. SAMEA Alternative to Antibiotics Sales Share by Type (2021-2032) Figure 65. SAMEA Alternative to Antibiotics Revenue Share by Application (2021-2032) Figure 66. SAMEA Alternative to Antibiotics Sales Share by Application (2021-2032) Figure 67. SAMEA Alternative to Antibiotics Revenue Share by Country (2021-2032) Figure 68. SAMEA Alternative to Antibiotics Sales Share by Country (2021-2032) Figure 69. Alternative to Antibiotics Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Alternative to Antibiotics Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Antimicrobial Proteins
  • Bacteriophages
  • Probiotics
  • Other
Applications
  • Drugs
  • Food & Beverage
  • Dietary Supplements
Companies covered
  • DSM
  • BioGaia
  • Bioriginal
  • Biosearch Life
  • China-Biotics
  • Chr. Hansen
  • Danone
  • DuPont(Danisco)
  • Ganeden
  • Glory Biotech
  • Greentech
  • Lallemand
  • Morinaga Milk Industry
  • Novozymes
  • Probi
  • Sabinsa
  • Synbiotech
  • UAS Laboratories
  • Valio
  • Yakult
  • Nestle

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alternative to Antibiotics Market by Type
  3. 1.2.1 Global Alternative to Antibiotics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antimicrobial Proteins
  5. 1.2.3 Bacteriophages
  6. 1.2.4 Probiotics
  7. 1.2.5 Other
  8. 1.3 Alternative to Antibiotics Market by Application
  9. 1.3.1 Global Alternative to Antibiotics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Drugs
  11. 1.3.3 Food & Beverage
  12. 1.3.4 Dietary Supplements
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Alternative to Antibiotics Market Dynamics
  1. 2.1 Alternative to Antibiotics Industry Trends
  2. 2.2 Alternative to Antibiotics Industry Drivers
  3. 2.3 Alternative to Antibiotics Industry Opportunities and Challenges
  4. 2.4 Alternative to Antibiotics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alternative to Antibiotics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alternative to Antibiotics Revenue by Region
  3. 3.2.1 Global Alternative to Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alternative to Antibiotics Revenue by Region (2021-2026)
  5. 3.2.3 Global Alternative to Antibiotics Revenue by Region (2027-2032)
  6. 3.2.4 Global Alternative to Antibiotics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alternative to Antibiotics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alternative to Antibiotics Sales by Region
  9. 3.4.1 Global Alternative to Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alternative to Antibiotics Sales by Region (2021-2026)
  11. 3.4.3 Global Alternative to Antibiotics Sales by Region (2027-2032)
  12. 3.4.4 Global Alternative to Antibiotics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alternative to Antibiotics Revenue by Manufacturers
  2. 4.1.1 Global Alternative to Antibiotics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alternative to Antibiotics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alternative to Antibiotics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alternative to Antibiotics Sales by Manufacturers
  6. 4.2.1 Global Alternative to Antibiotics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alternative to Antibiotics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alternative to Antibiotics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alternative to Antibiotics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alternative to Antibiotics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alternative to Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alternative to Antibiotics Manufacturers, Product Type & Application
  13. 4.7 Global Alternative to Antibiotics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alternative to Antibiotics Market CR5 and HHI
  16. 4.8.2 2025 Alternative to Antibiotics Tier 1, Tier 2, and Tier 3
5 Alternative to Antibiotics Market by Type
  1. 5.1 Global Alternative to Antibiotics Revenue by Type
  2. 5.1.1 Global Alternative to Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alternative to Antibiotics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alternative to Antibiotics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alternative to Antibiotics Sales by Type
  6. 5.2.1 Global Alternative to Antibiotics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alternative to Antibiotics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Alternative to Antibiotics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alternative to Antibiotics Price by Type
6 Alternative to Antibiotics Market by Application
  1. 6.1 Global Alternative to Antibiotics Revenue by Application
  2. 6.1.1 Global Alternative to Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alternative to Antibiotics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alternative to Antibiotics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alternative to Antibiotics Sales by Application
  6. 6.2.1 Global Alternative to Antibiotics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alternative to Antibiotics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Alternative to Antibiotics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alternative to Antibiotics Price by Application
7 Company Profiles
  1. 7.1 DSM
  2. 7.1.1 DSM Company Information
  3. 7.1.2 DSM Business Overview
  4. 7.1.3 DSM Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 DSM Alternative to Antibiotics Product Portfolio
  6. 7.1.5 DSM Recent Developments
  7. 7.2 BioGaia
  8. 7.2.1 BioGaia Company Information
  9. 7.2.2 BioGaia Business Overview
  10. 7.2.3 BioGaia Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 BioGaia Alternative to Antibiotics Product Portfolio
  12. 7.2.5 BioGaia Recent Developments
  13. 7.3 Bioriginal
  14. 7.3.1 Bioriginal Company Information
  15. 7.3.2 Bioriginal Business Overview
  16. 7.3.3 Bioriginal Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bioriginal Alternative to Antibiotics Product Portfolio
  18. 7.3.5 Bioriginal Recent Developments
  19. 7.4 Biosearch Life
  20. 7.4.1 Biosearch Life Company Information
  21. 7.4.2 Biosearch Life Business Overview
  22. 7.4.3 Biosearch Life Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biosearch Life Alternative to Antibiotics Product Portfolio
  24. 7.4.5 Biosearch Life Recent Developments
  25. 7.5 China-Biotics
  26. 7.5.1 China-Biotics Company Information
  27. 7.5.2 China-Biotics Business Overview
  28. 7.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
  30. 7.5.5 China-Biotics Recent Developments
  31. 7.6 Chr. Hansen
  32. 7.6.1 Chr. Hansen Company Information
  33. 7.6.2 Chr. Hansen Business Overview
  34. 7.6.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
  36. 7.6.5 Chr. Hansen Recent Developments
  37. 7.7 Danone
  38. 7.7.1 Danone Company Information
  39. 7.7.2 Danone Business Overview
  40. 7.7.3 Danone Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Danone Alternative to Antibiotics Product Portfolio
  42. 7.7.5 Danone Recent Developments
  43. 7.8 DuPont(Danisco)
  44. 7.8.1 DuPont(Danisco) Company Information
  45. 7.8.2 DuPont(Danisco) Business Overview
  46. 7.8.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
  48. 7.8.5 DuPont(Danisco) Recent Developments
  49. 7.9 Ganeden
  50. 7.9.1 Ganeden Company Information
  51. 7.9.2 Ganeden Business Overview
  52. 7.9.3 Ganeden Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ganeden Alternative to Antibiotics Product Portfolio
  54. 7.9.5 Ganeden Recent Developments
  55. 7.10 Glory Biotech
  56. 7.10.1 Glory Biotech Company Information
  57. 7.10.2 Glory Biotech Business Overview
  58. 7.10.3 Glory Biotech Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Glory Biotech Alternative to Antibiotics Product Portfolio
  60. 7.10.5 Glory Biotech Recent Developments
  61. 7.11 Greentech
  62. 7.11.1 Greentech Company Information
  63. 7.11.2 Greentech Business Overview
  64. 7.11.3 Greentech Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Greentech Alternative to Antibiotics Product Portfolio
  66. 7.11.5 Greentech Recent Developments
  67. 7.12 Lallemand
  68. 7.12.1 Lallemand Company Information
  69. 7.12.2 Lallemand Business Overview
  70. 7.12.3 Lallemand Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Lallemand Alternative to Antibiotics Product Portfolio
  72. 7.12.5 Lallemand Recent Developments
  73. 7.13 Morinaga Milk Industry
  74. 7.13.1 Morinaga Milk Industry Company Information
  75. 7.13.2 Morinaga Milk Industry Business Overview
  76. 7.13.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
  78. 7.13.5 Morinaga Milk Industry Recent Developments
  79. 7.14 Novozymes
  80. 7.14.1 Novozymes Company Information
  81. 7.14.2 Novozymes Business Overview
  82. 7.14.3 Novozymes Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novozymes Alternative to Antibiotics Product Portfolio
  84. 7.14.5 Novozymes Recent Developments
  85. 7.15 Probi
  86. 7.15.1 Probi Company Information
  87. 7.15.2 Probi Business Overview
  88. 7.15.3 Probi Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Probi Alternative to Antibiotics Product Portfolio
  90. 7.15.5 Probi Recent Developments
  91. 7.16 Sabinsa
  92. 7.16.1 Sabinsa Company Information
  93. 7.16.2 Sabinsa Business Overview
  94. 7.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
  96. 7.16.5 Sabinsa Recent Developments
  97. 7.17 Synbiotech
  98. 7.17.1 Synbiotech Company Information
  99. 7.17.2 Synbiotech Business Overview
  100. 7.17.3 Synbiotech Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Synbiotech Alternative to Antibiotics Product Portfolio
  102. 7.17.5 Synbiotech Recent Developments
  103. 7.18 UAS Laboratories
  104. 7.18.1 UAS Laboratories Company Information
  105. 7.18.2 UAS Laboratories Business Overview
  106. 7.18.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
  108. 7.18.5 UAS Laboratories Recent Developments
  109. 7.19 Valio
  110. 7.19.1 Valio Company Information
  111. 7.19.2 Valio Business Overview
  112. 7.19.3 Valio Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Valio Alternative to Antibiotics Product Portfolio
  114. 7.19.5 Valio Recent Developments
  115. 7.20 Yakult
  116. 7.20.1 Yakult Company Information
  117. 7.20.2 Yakult Business Overview
  118. 7.20.3 Yakult Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Yakult Alternative to Antibiotics Product Portfolio
  120. 7.20.5 Yakult Recent Developments
  121. 7.21 Nestle
  122. 7.21.1 Nestle Company Information
  123. 7.21.2 Nestle Business Overview
  124. 7.21.3 Nestle Alternative to Antibiotics Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Nestle Alternative to Antibiotics Product Portfolio
  126. 7.21.5 Nestle Recent Developments
8 North America
  1. 8.1 North America Alternative to Antibiotics Market Size by Type
  2. 8.1.1 North America Alternative to Antibiotics Revenue by Type (2021-2032)
  3. 8.1.2 North America Alternative to Antibiotics Sales by Type (2021-2032)
  4. 8.1.3 North America Alternative to Antibiotics Price by Type (2021-2032)
  5. 8.2 North America Alternative to Antibiotics Market Size by Application
  6. 8.2.1 North America Alternative to Antibiotics Revenue by Application (2021-2032)
  7. 8.2.2 North America Alternative to Antibiotics Sales by Application (2021-2032)
  8. 8.2.3 North America Alternative to Antibiotics Price by Application (2021-2032)
  9. 8.3 North America Alternative to Antibiotics Market Size by Country
  10. 8.3.1 North America Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alternative to Antibiotics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Alternative to Antibiotics Market Size by Type
  2. 9.1.1 Europe Alternative to Antibiotics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alternative to Antibiotics Sales by Type (2021-2032)
  4. 9.1.3 Europe Alternative to Antibiotics Price by Type (2021-2032)
  5. 9.2 Europe Alternative to Antibiotics Market Size by Application
  6. 9.2.1 Europe Alternative to Antibiotics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alternative to Antibiotics Sales by Application (2021-2032)
  8. 9.2.3 Europe Alternative to Antibiotics Price by Application (2021-2032)
  9. 9.3 Europe Alternative to Antibiotics Market Size by Country
  10. 9.3.1 Europe Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alternative to Antibiotics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Alternative to Antibiotics Market Size by Type
  2. 10.1.1 China Alternative to Antibiotics Revenue by Type (2021-2032)
  3. 10.1.2 China Alternative to Antibiotics Sales by Type (2021-2032)
  4. 10.1.3 China Alternative to Antibiotics Price by Type (2021-2032)
  5. 10.2 China Alternative to Antibiotics Market Size by Application
  6. 10.2.1 China Alternative to Antibiotics Revenue by Application (2021-2032)
  7. 10.2.2 China Alternative to Antibiotics Sales by Application (2021-2032)
  8. 10.2.3 China Alternative to Antibiotics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alternative to Antibiotics Market Size by Type
  2. 11.1.1 Asia Alternative to Antibiotics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alternative to Antibiotics Sales by Type (2021-2032)
  4. 11.1.3 Asia Alternative to Antibiotics Price by Type (2021-2032)
  5. 11.2 Asia Alternative to Antibiotics Market Size by Application
  6. 11.2.1 Asia Alternative to Antibiotics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alternative to Antibiotics Sales by Application (2021-2032)
  8. 11.2.3 Asia Alternative to Antibiotics Price by Application (2021-2032)
  9. 11.3 Asia Alternative to Antibiotics Market Size by Country
  10. 11.3.1 Asia Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alternative to Antibiotics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alternative to Antibiotics Market Size by Type
  2. 12.1.1 SAMEA Alternative to Antibiotics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alternative to Antibiotics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alternative to Antibiotics Price by Type (2021-2032)
  5. 12.2 SAMEA Alternative to Antibiotics Market Size by Application
  6. 12.2.1 SAMEA Alternative to Antibiotics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alternative to Antibiotics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alternative to Antibiotics Price by Application (2021-2032)
  9. 12.3 SAMEA Alternative to Antibiotics Market Size by Country
  10. 12.3.1 SAMEA Alternative to Antibiotics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alternative to Antibiotics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alternative to Antibiotics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alternative to Antibiotics Value Chain Analysis
  2. 13.1.1 Alternative to Antibiotics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alternative to Antibiotics Production Mode & Process
  6. 13.2 Alternative to Antibiotics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alternative to Antibiotics Distributors
  9. 13.2.3 Alternative to Antibiotics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst